Login / Signup

Falsified Drugs in the Opinion of Patients Diagnosed with Cardiovascular Diseases-Nationwide and Cross-Sectional Study on the Example of EU-Member Country.

Damian ŚwieczkowskiSzymon ZdanowskiPiotr MerksMiłosz Jaguszewski
Published in: International journal of environmental research and public health (2021)
Awareness of the risks associated with falsified drugs among patients with cardiovascular diseases remains high but still insufficient.
Keyphrases
  • cardiovascular disease
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • human health
  • patient reported